狂犬病疫苗市場報告：趨勢、預測和競爭分析（至 2031 年）

由於醫院、居家醫療和專科診所市場存在機會，全球狂犬病疫苗市場的未來前景光明。預計到 2031 年全球狂犬病疫苗市場規模將達到 13 億美元，2025 年至 2031 年的複合年成長率為 4.4%。市場的主要驅動力是人們對狂犬病風險的認知不斷提高，以及加強對狐狸和浣熊等野生動物狂犬病的控制力度。

• 根據產品類型，Lucintel 預測 Vero 細胞將是最有望在預測期內成長的細胞，因為它具有可行性、安全性和高免疫抗原性等諸多優點，並可用於暴露前和暴露後預防。
• 根據最終用途，由於醫院狂犬病疫苗接種處方數量的增加，預計市場將在預測期內見證最高成長。
• 按地區分類，北美憑藉其強大的醫療保健基礎設施和不斷成長的製藥公司數量將繼續成為最大的地區。

狂犬病疫苗市場的策略性成長機會

狂犬病疫苗市場在關鍵應用領域提供了多種策略成長機會。這些包括疫苗技術的進步、認知的提高和公共衛生舉措的加強。

• 人類疫苗接種計劃：人類狂犬病疫苗接種計劃的發展，特別是在高風險地區，代表著巨大的成長機會。改善服務取得途徑和進行有針對性的宣傳活動將有助於控制和預防疾病。
• 動物疫苗接種工作：對動物進行疫苗接種以防止狂犬病傳播的需求日益增加。透過專注於動物接種疫苗，我們可以控制狂​​犬病的發生並減少人類的感染。
• 聯合疫苗的開發：提供可以預防多種疾病的聯合疫苗也是一個成長機會。這樣的疫苗接種計畫會更簡單，病人也更容易遵守。
• 創新的給藥方法：另一種可能性是研究創新的疫苗給藥方法，例如微針貼片或口服疫苗。這些可以幫助提高疫苗接受度並使接種疫苗更加方便。
• 擴大市場進入：改善分銷和物流將增加新興市場的准入，為市場擴張提供機會。這些努力將確保先前稀缺的疫苗能夠在醫療資源匱乏的地區更廣泛地普及，從而促進更大的市場滲透。

這些成長機會正在推動創新、擴大獲取途徑和改善疾病控制，從而塑造狂犬病疫苗市場。需要應對這些挑戰，才能有效解決全球狂犬病問題並加強公共衛生干預。

狂犬病疫苗市場促進因素與挑戰

狂犬病疫苗市場受到各種市場促進因素和挑戰的影響，包括技術進步、經濟因素和監管考量。了解這些因素對於市場發展至關重要。

推動狂犬病疫苗市場發展的因素有：

• 技術進步：疫苗技術市場的成長受到創新重組和組合疫苗的推動。這些變化提高了產品的安全性和有效性，並改善了疾病控制。
• 提高意識和教育：人們對狂犬病及其疫苗接種的認知不斷提高，導致對疫苗的需求增加。因此，需要開展健康宣傳活動和教育活動來提高疫苗接種覆蓋率。
• 政府舉措：政府的支持政策和狂犬病疫苗接種計劃的資金推動了市場擴張。政府在擴大疫苗接種覆蓋率和控制疫情方面的作用怎麼強調也不為過。
• 擴大疫苗接種管道：改進的分發系統和物流使服務不足的社區能夠獲得疫苗，並接種比以往更多的疫苗。改進的低溫運輸管理加上有針對性的計劃正在促進疫苗的廣泛普及。
• 研究與開發：疫苗技術的創新仍在繼續，包括新的輸送系統。如果沒有這些研究和開發，我們就沒有機會開發更有效、更方便的疫苗接種方法。

狂犬病疫苗市場面臨的挑戰是：

• 監管障礙：由於監管要求複雜，在產品開發過程中以及嘗試獲得疫苗核准時遵守各種國際標準可能會很困難。疫苗的核准過程很困難，因為必須滿足國際上的多項標準，這使得產品開發和市場開發變得複雜。
• 高成本：開發和生產先進疫苗的成本非常高，這會影響定價和可負擔性，特別是在非洲等狂犬病高度流行的資源貧乏的國家。生產此類疫苗需要大量資金，成本昂貴。
• 疫苗猶豫：提高疫苗接種率取決於解決疫苗猶豫和錯誤訊息。消除接受疫苗的障礙需要公眾教育和參與。

這些市場促進因素和挑戰影響了創新、取得和公共衛生計劃，從而對狂犬病疫苗市場產生了重大影響。解決這些因素將改善狂犬病控制並提高疫苗接種覆蓋率。

目錄

第1章執行摘要

第 2 章全球狂犬病疫苗市場：市場動態

• 簡介、背景和分類
• 供應鏈
• 產業促進因素與挑戰

第 3 章 市場趨勢與預測分析（2019-2031）

• 宏觀經濟趨勢（2019-2024）與預測（2025-2031）
• 全球狂犬病疫苗市場趨勢（2019-2024 年）及預測（2025-2031 年）
• 全球狂犬病疫苗市場（依產品類型）
  • BHK（幼倉鼠腎）
  • 狂犬病精製雞胚細胞疫苗
  • 狂犬病 Vero 細胞疫苗
  • 其他
• 全球狂犬病疫苗市場（依疫苗類型分類）
  • 暴露前疫苗接種（PEV）
  • 暴露後預防（PEP）
• 全球狂犬病疫苗市場（按應用）
  • 動物
  • 人類
• 全球狂犬病疫苗市場（依最終用途分類）
  • 醫院
  • 居家醫療
  • 專科門診
  • 其他

第 4 章區域市場趨勢與預測分析（2019-2031 年）

• 全球狂犬病疫苗市場（按區域）
• 北美狂犬病疫苗市場
• 歐洲狂犬病疫苗市場
• 亞太地區狂犬病疫苗市場
• 世界其他地區狂犬病疫苗市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球狂犬病疫苗市場按產品類型分類的成長機會
  • 全球狂犬病疫苗市場成長機會（依疫苗類型分類）
  • 全球狂犬病疫苗市場成長機會（按應用）
  • 全球狂犬病疫苗市場成長機會（依最終用途分類）
  • 全球狂犬病疫苗市場各區域成長機會
• 全球狂犬病疫苗市場的新趨勢
• 戰略分析
  • 新產品開發
  • 全球狂犬病疫苗市場產能擴張
  • 全球狂犬病疫苗市場的企業合併
  • 認證和許可

第7章主要企業簡介

• Serum Institute of India
• Novartis
• Cadila Pharmaceuticals
• Merck
• Sanofi
• ADS Diagnostic
• GSK

The future of the global rabies vaccine market looks promising with opportunities in the hospital, home care, and specialty clinic markets. The global rabies vaccine market is expected to reach an estimated $1.3 billion by 2031 with a CAGR of 4.4% from 2025 to 2031. The major drivers for this market are the rising awareness of the risks of rabies and growing efforts to control rabies in wildlife populations, such as foxes and raccoons.

• Lucintel forecasts that, within the product type category, vero cell is expected to witness the highest growth over the forecast period due to its numerous benefits, such as its feasibility, safety, and high immunogenicity, and its use for pre-and post-exposure prophylaxis.
• Within the end-use category, the hospital is expected to witness the highest growth over the forecast period due to the increasing number of rabies vaccination prescriptions issued within these facilities.
• In terms of regions, North America will remain the largest region due to its robust healthcare infrastructure and the growing number of pharmaceutical companies in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Rabies Vaccine Market

Numerous technological advancements, changing healthcare needs, and an increasing global focus on disease prevention are driving the current trends in the rabies vaccine market.

• Enhanced Vaccine Technologies: These include recombinant and DNA vaccines that have improved their effectiveness and safety profiles for rabies vaccination. They offer more efficacious and less mild alternatives to the existing rabies vaccines.
• Combination Vaccines: More people today prefer combination vaccines that protect against multiple diseases, including rabies. This simplifies vaccination schedules and promotes compliance among patients.
• Expanded Access and Distribution: Currently, there is a growing focus on expanding access to low-cost rabies vaccines in low-resource settings. Better distribution networks and public health awareness campaigns are leading to higher immunization coverage rates, thus helping to control these diseases.
• Increased Focus on Animal Vaccination: In high rabies incidence areas, animal vaccination is now more important than ever before. Failure to vaccinate animals implies that humans can be affected as a consequence of an outbreak of this disease.
• Novel Delivery Methods: Ongoing studies are exploring novel methods of administering vaccines, such as microneedle patches and oral vaccines, to make vaccination more effective, especially for humans and animals.

These trends improve vaccine technology and expand access while enhancing other disease prevention strategies, thereby reshaping the rabies vaccine market, which contributes significantly to better overall worldwide control measures against rabies.

Recent Developments in the Rabies Vaccine Market

The rabies vaccine market is experiencing considerable progress as a result of technological innovation, regulatory amendments, and increased concern for disease prevention. These developments are shaping the future of rabies vaccination.

• Recombinant Vaccines: The introduction of recombinant rabies vaccines has made them safer and more effective. They involve genetic engineering, leading to newer, better immunizations with fewer side effects.
• Expanded Vaccination Campaigns: Global efforts to expand rabies vaccination campaigns are leading to greater coverage in high-risk areas. These interventions encompass human and animal vaccination schemes designed to contain outbreaks.
• Combination Vaccines: The development of combination vaccines that prevent multiple diseases is gaining momentum. Such vaccines make it easier to immunize many people at once and thus contribute positively to public health outcomes.
• Improved Distribution Networks: Advances in distribution and logistics have improved accessibility to rabies vaccines in remote and underserved areas. This includes better cold chain management and targeted vaccination programs.
• Innovative Research: Continued research on alternative vaccine technologies, such as oral vaccines and microneedle vaccinations, is advancing the field. These innovations aim to enhance vaccine delivery methods and improve patient compliance, among other goals.

By enhancing vaccine safety, increasing availability, and driving innovation, these developments significantly impact the rabies vaccine market. They are important in improving worldwide efforts to control this disease by preventing its spread through various channels.

Strategic Growth Opportunities for Rabies Vaccine Market

The rabies vaccine market offers several strategic growth opportunities in major applications. These include technological advancements in vaccines, improved awareness, and increased public health initiatives.

• Human Vaccination Programs: Developing human rabies vaccination programs, particularly in high-risk regions, represents a huge opportunity for growth. The control and prevention of disease can be facilitated through better access to services and focused campaigns.
• Animal Vaccination Initiatives: There is an increasing need to vaccinate animals to prevent the spread of rabies. Concentrating more on animal vaccinations will help control outbreaks and decrease human cases.
• Combination Vaccine Development: Offering combination vaccines that can prevent multiple illnesses is another area of opportunity for growth. Immunization schedules for these vaccines will be easier, making it easier for patients to comply with them.
• Innovative Delivery Methods: Another possibility is research into innovative vaccine delivery methods, such as microneedle patches and oral vaccines, which have growth potential. They can help enhance vaccine acceptance rates and make the doses more convenient.
• Expanded Market Access: Improvement in distribution and logistics, leading to better accessibility in emerging markets, presents expansion opportunities. Such efforts would result in wider availability of previously scarce vaccines across underserved sectors, thereby driving further market penetration.

These growth opportunities are shaping the rabies vaccine market by fostering innovation while also expanding access and improving disease control measures. They must be addressed if global rabies issues are to be dealt with effectively, thus enhancing public health interventions.

Rabies Vaccine Market Driver and Challenges

The rabies vaccine market is influenced by various drivers and challenges, including technological advancements, economic factors, and regulatory considerations. Understanding these elements is crucial for market development.

The factors responsible for driving the rabies vaccine market include:

• Technological Advancements: Market growth in vaccine technology can be attributed to innovative recombinant and combination vaccines. These changes have made it possible to control diseases better by increasing product safety and effectiveness.
• Increased Awareness and Education: Demand for vaccines is increasing due to improved awareness about rabies and its prevention through vaccination. Therefore, health campaigns and educational efforts are necessary for enhancing vaccination rates.
• Government Initiatives: Market expansion has been fueled by supportive government policies and funding for rabies vaccination programs. The role played by governments in scaling up immunization coverage and controlling outbreaks cannot be overemphasized.
• Expanded Access to Vaccines: Better distribution systems and logistics are making underserved areas more accessible, enabling them to receive more vaccines than before. Improved cold chain management, coupled with targeted programs, facilitates wider availability of vaccines.
• Research and Development: There is ongoing innovation in vaccine technologies, such as new delivery systems. Without this research, there would be no opportunity to develop more effective or convenient ways of vaccinating people.

Challenges in the rabies vaccine market include:

• Regulatory Hurdles: Complying with different international standards during product development or when trying to obtain approval for a vaccine can be difficult due to complex regulatory requirements. This makes navigating procedures for vaccine approval challenging and complicates product development and market entry due to the multiple standards that must be met internationally.
• High Costs: The developing and manufacturing costs associated with advanced vaccines can be very high, impacting pricing and affordability, particularly among low-resource countries where rabies is highly prevalent, such as in Africa. Producing these types of vaccines requires a significant amount of funding, creating high costs.
• Vaccine Hesitancy: Increasing vaccination rates hinges on addressing vaccine hesitancy and misinformation. Public education and engagement are required to remove barriers to vaccine acceptance.

These drivers and challenges significantly impact the rabies vaccine market by influencing innovation, access, and public health efforts. Rabies control can be improved, and vaccination coverage extended by addressing these elements.

List of Rabies Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies rabies vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the rabies vaccine companies profiled in this report include-

• Serum Institute of India
• Novartis
• Cadila Pharmaceuticals
• Merck
• Sanofi
• ADS Diagnostic
• GSK

Rabies Vaccine by Segment

The study includes a forecast for the global rabies vaccine market by product type, vaccination type, application, end use, and region.

Rabies Vaccine Market by Product Type [Analysis by Value from 2019 to 2031]:

• Baby Hamster Kidney
• Purified Chick Embryo Cell Rabies Vaccine
• Vero Cell Rabies Vaccine
• Others

Rabies Vaccine Market by Vaccination Type [Analysis by Value from 2019 to 2031]:

• Pre-Exposure Vaccination (PEV)
• Post-Exposure Prophylaxis (PEP)

Rabies Vaccine Market by Application [Analysis by Value from 2019 to 2031]:

• Animal
• Human

Rabies Vaccine Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Homecare
• Specialty Clinics
• Others

Rabies Vaccine Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Rabies Vaccine Market

The rabies vaccine market is changing rapidly due to progress in vaccine technology, increased awareness, and differing global health priorities. These trends are evident in recent developments in the United States, China, Germany, India, and Japan, which demonstrate global efforts to curb and prevent rabies.

• USA: New safety-enhanced rabies vaccines with improved post-exposure prophylaxis regimens have been developed. Recent research has led to recombinant vaccines that are more effective and have fewer side effects.
• China: Rabies vaccination programs are being expanded in China, especially in rural areas where the disease is rampant. The government has also increased funding for vaccination campaigns and studies on more potent vaccines.
• Germany: Germany's focus has shifted toward combination vaccines offering protection against many diseases, including rabies. This approach aims to create a consolidated immunization program that will increase the number of immunized individuals.
• India: New intervention programs revolve around the wider distribution of anti-rabies vaccines among vulnerable communities. Access to vaccines will be improved by conducting campaigns in public health systems and partnering with organizations involved in immunization.
• Japan: In Japan, investments in advanced research on rabies vaccinations, including novel delivery mechanisms, have been made. These innovations aim to improve the efficacy of vaccines, particularly for travelers and pet owners who prioritize convenience.

Features of the Global Rabies Vaccine Market

Market Size Estimates: Rabies vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Rabies vaccine market size by various segments, such as by product type, vaccination type, application, end use, and region in terms of ($B).

Regional Analysis: Rabies vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, vaccination types, applications, end uses, and regions for the rabies vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the rabies vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the rabies vaccine market by product type (baby hamster kidney, purified chick embryo cell rabies vaccine, vero cell rabies vaccine, and others), vaccination type (pre-exposure vaccination (PEV) and post-exposure prophylaxis (PEP)), application (animal and human), end use (hospitals, homecare, specialty clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Rabies Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Rabies Vaccine Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Rabies Vaccine Market by Product Type
  • 3.3.1: Baby Hamster Kidney
  • 3.3.2: Purified Chick Embryo Cell Rabies Vaccine
  • 3.3.3: Vero Cell Rabies Vaccine
  • 3.3.4: Others
• 3.4: Global Rabies Vaccine Market by Vaccination Type
  • 3.4.1: Pre-Exposure Vaccination (PEV)
  • 3.4.2: Post-Exposure Prophylaxis (PEP)
• 3.5: Global Rabies Vaccine Market by Application
  • 3.5.1: Animal
  • 3.5.2: Human
• 3.6: Global Rabies Vaccine Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Homecare
  • 3.6.3: Specialty Clinics
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Rabies Vaccine Market by Region
• 4.2: North American Rabies Vaccine Market
  • 4.2.1: North American Market by Product Type: Baby Hamster Kidney, Purified Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, and Others
  • 4.2.2: North American Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
• 4.3: European Rabies Vaccine Market
  • 4.3.1: European Market by Product Type: Baby Hamster Kidney, Purified Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, and Others
  • 4.3.2: European Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
• 4.4: APAC Rabies Vaccine Market
  • 4.4.1: APAC Market by Product Type: Baby Hamster Kidney, Purified Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, and Others
  • 4.4.2: APAC Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others
• 4.5: ROW Rabies Vaccine Market
  • 4.5.1: ROW Market by Product Type: Baby Hamster Kidney, Purified Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, and Others
  • 4.5.2: ROW Market by End Use: Hospitals, Homecare, Specialty Clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Rabies Vaccine Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Rabies Vaccine Market by Vaccination Type
  • 6.1.3: Growth Opportunities for the Global Rabies Vaccine Market by Application
  • 6.1.4: Growth Opportunities for the Global Rabies Vaccine Market by End Use
  • 6.1.5: Growth Opportunities for the Global Rabies Vaccine Market by Region
• 6.2: Emerging Trends in the Global Rabies Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Rabies Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Rabies Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Serum Institute of India
• 7.2: Novartis
• 7.3: Cadila Pharmaceuticals
• 7.4: Merck
• 7.5: Sanofi
• 7.6: ADS Diagnostic
• 7.7: GSK